Strata Critical Medical Inc(SRTA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.19 | Insider Own | 24.8% | Shs Outstand | 88.5M | Perf Week | -3.26% |
| Market Cap | 0.46B | Forward P/E | 1560.06 | EPS next Y | 103.6% | Insider Trans | -0.64% | Shs Float | 66.5M | Perf Month | -13.85% |
| Enterprise Value | 0.44B | PEG | - | EPS next Q | -0.01 | Inst Own | 60.61% | Short Float | 6.8% | Perf Quarter | -5.37% |
| Income | -0.02B | P/S | 1.8 | EPS this Y | 63.39% | Inst Trans | -2.13% | Short Ratio | 4.02 | Perf Half Y | 11.6% |
| Sales | 0.26B | P/B | 1.65 | EPS next 5Y | - | ROA | -7.84% | Short Interest | 4.53M | Perf YTD | 8% |
| Book/sh | 3.16 | P/C | 19.96 | EPS past 3/5Y | 20.73% 20.42% | ROE | -9.22% | 52W High | -20.08% ($6.50) | Perf Year | 23.4% |
| Cash/sh | 0.26 | P/FCF | - | Sales past 3/5Y | 10.5% - | ROIC | -5.82% | 52W Low | 31.52% ($3.95) | Perf 3Y | 65.45% |
| Dividend Est. | - | EV/EBITDA | 53.37 | EPS Y/Y TTM | 19.57% | Gross Margin | 16.67% | Volatility(W/M) | 2.9% 3.73% | Perf 5Y | -47.26% |
| Dividend TTM | - | EV/Sales | 1.72 | Sales Y/Y TTM | 0.64% | Oper. Margin | -3.04% | ATR (14) | 0.23 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.64 | EPS Q/Q | -165.22% | Profit Margin | -6.42% | RSI (14) | 38.31 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.64 | Sales Q/Q | 2.41% | SMA20 | -8.84% ($5.7) | Beta | 2.43 | Target Price | $9.56 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2026/8/4 | SMA50 | -5.38% ($5.5) | Rel Volume | 0.68 | Prev Close | $5.13 |
| Employees | 601 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -500% 7.24% | SMA200 | 1.6% ($5.12) | Avg Volume(3M) | 1.13M | Price | $5.2 |
| IPO | 2019/11/5 | Option/Short | Yes/Yes | Trades | 5544 | Volume | 770,177 | Change | 1.27% |
Company
SRTA is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🫀 Strata Critical Medical (ticker SRTA) is a U.S. healthcare facility company whose core business centers on organ transplant logistics and clinical support services. The company previously operated in the air mobility sector before shifting its focus toward medical logistics, and is steadily expanding its footprint in non-discretionary demand areas such as organ transportation and cardiovascular surgical support.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
SRTA has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +63.4% this year.
Tap to view numbers
The stock looks undervalued
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +65.5% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 60.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
ARKX 0.02%
ARKQ 0.01%
XHS 0.00%
IWC 0.00%
OMFS 0.00%It ranks #4 in the industry
Based on market cap of $460M.
SRTA $460M PER -
HCA $92B PER 14.3
THC $21B PER 10.2
EHC $12B PER 19.8
FAQ
What kind of company is SRTA?
SRTA belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of SRTA?
The market cap of SRTA is approximately $460M, ranking 3,297 within its sector.
What is the 52-week high and low for SRTA?
SRTA has recorded a 52-week high of $6.50 and a low of $3.95.
